LI Lu-chun, et al. Research on the relation between expression GRP78 in gastric cancer cell lines and its sensitivity to chemotherapeutic drugs[J]. Journal of Chongqing Medical University, 2011,36(1):46-50.
LI Lu-chun, et al. Research on the relation between expression GRP78 in gastric cancer cell lines and its sensitivity to chemotherapeutic drugs[J]. Journal of Chongqing Medical University, 2011,36(1):46-50. DOI: 10.13406/j.cnki.cyxb.2011.01.027.
Objective:To research the sensitivity of different gastric cancer cell lines to chemotherapeutic drugs and evaluate GRP78 expression in order to analyze the relation between them.Methods:The SGC7901 cells were treated by calcium ionophore A23187 and Ca2+ chelator BAPTA-AM.The sensitivity of different gastric cancer cell lines to different chemotherapeutic drugs was detected by MTT assay.The expression of GRP78 was assessed by RT-PCR and Western blot.The expression of AKT/PKB in SGC7901
A23187-SGC7901 and BAPTA-AM-SGC7901 was analyzed by Western blot.Cell apoptosis was analyzed by flow cytometry in order to evaluate the therapeutic sensitivity to VCR.Results:GRP78 was expressed in all of the three gastric cancer cell lines.The expression of GRP78 at both protein and mRNA levels was the lowest in NCI-N87 cell
whose sensitivity to different chemotherapeutic drugs was the highest one.The expression of GRP78 at both protein and mRNA levels was the highest in MKN45 cell
whose sensitivity to different chemotherapeutic drugs was the lowest one.GRP78 was up-regulated and down-regulated by A23187 and BAPTA-AM respectively in gastric cancer cell line SGC7901.The sensitivity to VCR was the highest in BAPTA-AM-SGC7901
whose expression of AKT/PKB was the lowest one.On the contrary
the sensitivity to VCR was the lowest in A23187-SGC7901 whose expression of AKT/PKB was the highest.Conclusion:The expression of GRP78 in three gastric cancer cells is diverse
and the sensitivity of those cells to chemotherapeutic drugs is also different.Altering expression of GRP78 in gastric cancer cell can affect its downstream protein AKT/PKB expression levels
thereby affecting the sensitivity of gastric cancer cells to chemo-therapeutic drugs.